UK markets closed

BIOLASE, Inc. (BIOL)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1768+0.0317 (+21.85%)
At close: 04:00PM EDT
0.1661 -0.01 (-6.05%)
After hours: 06:07PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-20,632
-20,632
-28,634
-16,158
-16,829
Depreciation & amortisation
2,798
2,798
497
400
499
Deferred income taxes
-
-
-
0
0
Stock-based compensation
1,232
1,232
2,303
1,662
3,370
Change in working capital
1,025
1,025
-5,070
5
1,754
Accounts receivable
201
201
-1,643
-978
4,286
Inventory
969
969
-5,754
-1,375
-871
Accounts payable
-
-
-
-
-2,107
Other working capital
-15,402
-15,402
-30,488
-17,417
-12,891
Other non-cash items
873
873
1,305
994
496
Net cash provided by operating activities
-14,091
-14,091
-26,761
-16,710
-12,795
Cash flows from investing activities
Investments in property, plant and equipment
-1,311
-1,311
-3,727
-707
-96
Net cash used for investing activities
-1,129
-1,129
-3,727
-707
-96
Cash flows from financing activities
Debt repayment
-165
-165
-1,000
0
-3,700
Common stock issued
9,553
9,553
5,602
14,420
6,912
Other financing activities
-
-
-
-1,160
-3,049
Net cash used provided by (used for) financing activities
17,434
17,434
4,603
29,954
24,349
Net change in cash
2,385
2,385
-25,994
12,299
11,775
Cash at beginning of period
4,181
4,181
30,175
17,876
6,101
Cash at end of period
6,566
6,566
4,181
30,175
17,876
Free cash flow
Operating cash flow
-14,091
-14,091
-26,761
-16,710
-12,795
Capital expenditure
-1,311
-1,311
-3,727
-707
-96
Free cash flow
-15,402
-15,402
-30,488
-17,417
-12,891